<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>theHeart.org via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'theHeart.org' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=theHeart.org&t=theHeart.org&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 09:33:01 +0100</lastBuildDate>
        <item>
            <title>Braile Biomédica launches transapical valve</title>
            <link>http://www.medworm.com/index.php?rid=5667054&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1353151.do</link>
            <description>A Brazilian group says they're encouraged by the early results with their transapical transcatheter aortic valve. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667054</comments>
            <pubDate>Tue, 07 Feb 2012 21:30:12 +0100</pubDate>
            <guid isPermaLink="false">5667054</guid>        </item>
        <item>
            <title>Wake-up stroke patients may still benefit from thrombolysis</title>
            <link>http://www.medworm.com/index.php?rid=5667055&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1353003.do</link>
            <description>A new study shows tPA was safe for patients who woke up with stroke symptoms, a population not normally treated since they could exceed the 4.5-hour window. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667055</comments>
            <pubDate>Tue, 07 Feb 2012 20:00:01 +0100</pubDate>
            <guid isPermaLink="false">5667055</guid>        </item>
        <item>
            <title>Generalists need education on HF treatment</title>
            <link>http://www.medworm.com/index.php?rid=5667056&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1352971.do</link>
            <description>A unique study trying to drill down into why cardiologists seem to gain better outcomes than generalists when treating heart failure has identified a number of reasons that this is the case. But generalists&amp;#x2014;who treat the majority of HF&amp;#x2014;have to deal with older and sicker patients, confounding the issue. The authors hope the work will act as a catalyst to improve HF care. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667056</comments>
            <pubDate>Tue, 07 Feb 2012 19:00:09 +0100</pubDate>
            <guid isPermaLink="false">5667056</guid>        </item>
        <item>
            <title>SWITCH III: Bivalirudin is as safe as heparin after fondaparinux in PCI patients</title>
            <link>http://www.medworm.com/index.php?rid=5667057&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1352847.do</link>
            <description>Recent studies have shown that ACS patients on fondaparinux prior to PCI should switch to another anticoagulant prior to the procedure to avoid thrombus. The SWITCH III trial compares bivalirudin and unfractionated heparin in a small group of these patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667057</comments>
            <pubDate>Tue, 07 Feb 2012 17:30:10 +0100</pubDate>
            <guid isPermaLink="false">5667057</guid>        </item>
        <item>
            <title>TRA 2°P: Vorapaxar meets end point but ups bleeding</title>
            <link>http://www.medworm.com/index.php?rid=5667058&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1352901.do</link>
            <description>In its second phase 3 trial, Merck's novel antiplatelet agent reduced ischemic events but increased bleeding, including ICH. Results looked more promising in patients without a history of stroke. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667058</comments>
            <pubDate>Tue, 07 Feb 2012 17:20:03 +0100</pubDate>
            <guid isPermaLink="false">5667058</guid>        </item>
        <item>
            <title>CTO, even in non-infarct-related artery, bodes ill in NSTEMI patients</title>
            <link>http://www.medworm.com/index.php?rid=5667059&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1352229.do</link>
            <description>Swedish researchers examined SCAAR to determine the prognostic significance of a chronic total occlusion in an artery other than the infarct-related one of non-ST-elevation-MI patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667059</comments>
            <pubDate>Tue, 07 Feb 2012 14:45:51 +0100</pubDate>
            <guid isPermaLink="false">5667059</guid>        </item>
        <item>
            <title>ICDs charged with sex discrimination: Women get fewer shocks</title>
            <link>http://www.medworm.com/index.php?rid=5667060&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351717.do</link>
            <description>Differences in appropriate-therapy and device-related complication rates in a prospective study question (once again) whether women and men should have the same ICD-eligibility criteria. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667060</comments>
            <pubDate>Mon, 06 Feb 2012 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667060</guid>        </item>
        <item>
            <title>MI-shock proposal is cold comfort: Hypothermia might boost survival</title>
            <link>http://www.medworm.com/index.php?rid=5667062&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1352015.do</link>
            <description>Some data suggest therapeutic hypothermia might reduce the currently high mortality from cardiogenic shock; let's do the necessary clinical studies to see whether it might be true, urges a published viewpoint. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667062</comments>
            <pubDate>Mon, 06 Feb 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667062</guid>        </item>
        <item>
            <title>Fitness and fatness independently linked with CVD risk factors</title>
            <link>http://www.medworm.com/index.php?rid=5667061&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351677.do</link>
            <description>Individuals should be aware that exercising can have positive health effects, even if the weight doesn't necessarily come off, as can losing weight alone, researchers say, although the ideal combination is to improve fitness and lose fat. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667061</comments>
            <pubDate>Mon, 06 Feb 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667061</guid>        </item>
        <item>
            <title>Dr Paolo Raggi joins University of Alberta</title>
            <link>http://www.medworm.com/index.php?rid=5667063&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351963.do</link>
            <description>Dr Paolo Raggi has been named the academic director of the Mazankowski Alberta Heart Institute at the University of Alberta in Edmonton and chief of cardiology at Alberta Health Services. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667063</comments>
            <pubDate>Mon, 06 Feb 2012 19:45:19 +0100</pubDate>
            <guid isPermaLink="false">5667063</guid>        </item>
        <item>
            <title>Lower mortality in NFL players—if weight is kept in check</title>
            <link>http://www.medworm.com/index.php?rid=5667064&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351901.do</link>
            <description>The reduction in mortality and cardiovascular disease was observed in the smaller players&amp;#x2014;defensive backs, quarterbacks, and wide receivers, as well as fullbacks, halfbacks, and running backs, among others. For the true giants of the gridiron, the linemen, cardiovascular disease mortality was not significantly reduced compared with the US population. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667064</comments>
            <pubDate>Mon, 06 Feb 2012 19:15:21 +0100</pubDate>
            <guid isPermaLink="false">5667064</guid>        </item>
        <item>
            <title>KEEP: Focus on CKD patients with highest SBP</title>
            <link>http://www.medworm.com/index.php?rid=5667065&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351835.do</link>
            <description>A new, contemporary study in real-world patients with chronic kidney disease finds that those with systolic BPs of 140 mm Hg and higher are at the greatest risk of developing end-stage renal disease. Hence the current &quot;goal&quot; in CKD patients of 130 mm Hg should be revised upward, say the authors, making the target easier to achieve and allowing physicians to focus on other aspects of care. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667065</comments>
            <pubDate>Mon, 06 Feb 2012 17:30:06 +0100</pubDate>
            <guid isPermaLink="false">5667065</guid>        </item>
        <item>
            <title>&quot;Irrational&quot; choices stall adoption of new antiplatelets</title>
            <link>http://www.medworm.com/index.php?rid=5667066&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351485.do</link>
            <description>Dr David Cohen points out some of physicians' potential &quot;psychological&quot; barriers to more rapid adoption of new antiplatelet agents, even though they may be the best choice for their patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667066</comments>
            <pubDate>Mon, 06 Feb 2012 14:15:50 +0100</pubDate>
            <guid isPermaLink="false">5667066</guid>        </item>
        <item>
            <title>Sitagliptin/metformin once-daily combo approved for diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5659582&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351421.do</link>
            <description>The extended-release combination of sitagliptin and metformin joins saxagliptin/metformin as a once-daily tablet for type 2 diabetes. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659582</comments>
            <pubDate>Fri, 03 Feb 2012 23:00:59 +0100</pubDate>
            <guid isPermaLink="false">5659582</guid>        </item>
        <item>
            <title>No recurrent stroke prevention seen with clopidogrel plus aspirin</title>
            <link>http://www.medworm.com/index.php?rid=5659583&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351385.do</link>
            <description>A new study shows that the combination of clopidogrel and aspirin increases risk of hemorrhage and mortality, including nonvascular mortality, vs aspirin alone. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659583</comments>
            <pubDate>Fri, 03 Feb 2012 22:15:57 +0100</pubDate>
            <guid isPermaLink="false">5659583</guid>        </item>
        <item>
            <title>Heart failure linked to loss of brain gray matter</title>
            <link>http://www.medworm.com/index.php?rid=5659584&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351245.do</link>
            <description>Heart failure is associated with a decline in mental function and loss of gray matter in the brain, which may make it more difficult for patients to follow instructions regarding their medication, a new Australian study has found. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659584</comments>
            <pubDate>Fri, 03 Feb 2012 21:15:21 +0100</pubDate>
            <guid isPermaLink="false">5659584</guid>        </item>
        <item>
            <title>Photos on school lunch trays boost veggie intake</title>
            <link>http://www.medworm.com/index.php?rid=5659585&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351207.do</link>
            <description>A simple intervention, whereby photographs of green beans and carrots were placed in lunch trays in a school cafeteria, has had some success in boosting consumption of these vegetables among elementary schoolchildren. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659585</comments>
            <pubDate>Fri, 03 Feb 2012 20:45:11 +0100</pubDate>
            <guid isPermaLink="false">5659585</guid>        </item>
        <item>
            <title>Aspirin as effective as warfarin in heart failure: WARCEF</title>
            <link>http://www.medworm.com/index.php?rid=5659586&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1351077.do</link>
            <description>Although there was an edge for warfarin for those treated for four or more years, there is &quot;no compelling&quot; reason to anticoagulate these patients, researchers say. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659586</comments>
            <pubDate>Fri, 03 Feb 2012 19:55:27 +0100</pubDate>
            <guid isPermaLink="false">5659586</guid>        </item>
        <item>
            <title>&quot;Tetherless&quot; power-transmission technology could radically change LVAD therapy</title>
            <link>http://www.medworm.com/index.php?rid=5659587&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1350709.do</link>
            <description>New wireless technology used to power implantable ventricular assist devices has the potential to make them far safer than ever before and bring the therapy to patients at earlier stages of heart failure than are currently recommended. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659587</comments>
            <pubDate>Fri, 03 Feb 2012 16:00:14 +0100</pubDate>
            <guid isPermaLink="false">5659587</guid>        </item>
        <item>
            <title>CMS draft of proposed coverage for TAVI</title>
            <link>http://www.medworm.com/index.php?rid=5659588&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1350625.do</link>
            <description>The CMS has issued a draft of the conditions under which it will provide coverage for transcatheter aortic-valve replacements, as the technology begins to be rolled out in the US. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659588</comments>
            <pubDate>Fri, 03 Feb 2012 14:30:30 +0100</pubDate>
            <guid isPermaLink="false">5659588</guid>        </item>
        <item>
            <title>Severe anemia potent predictor of death poststroke</title>
            <link>http://www.medworm.com/index.php?rid=5659589&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1350487.do</link>
            <description>Study results should prompt physicians to take a closer look at what's causing anemia in stroke patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659589</comments>
            <pubDate>Thu, 02 Feb 2012 22:15:49 +0100</pubDate>
            <guid isPermaLink="false">5659589</guid>        </item>
        <item>
            <title>Cardiac telemetry identifies AF in cryptogenic stroke</title>
            <link>http://www.medworm.com/index.php?rid=5659590&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1350413.do</link>
            <description>Outpatient monitoring for 21 days detected atrial fibrillation in 17% of patients, and this could change management. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659590</comments>
            <pubDate>Thu, 02 Feb 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659590</guid>        </item>
        <item>
            <title>The flap over flavonoids</title>
            <link>http://www.medworm.com/index.php?rid=5659591&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1349603.do</link>
            <description>The field of flavonoids and polyphenols continues to attract a massive amount of interest, from researchers and the public alike. But can health really be improved by eating chocolate and drinking red wine? (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659591</comments>
            <pubDate>Thu, 02 Feb 2012 20:15:40 +0100</pubDate>
            <guid isPermaLink="false">5659591</guid>        </item>
        <item>
            <title>Severe, rapid memory loss could herald stroke</title>
            <link>http://www.medworm.com/index.php?rid=5659592&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1350083.do</link>
            <description>A new study finds that victims of fatal stroke had sharp memory declines before the event. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659592</comments>
            <pubDate>Thu, 02 Feb 2012 19:15:18 +0100</pubDate>
            <guid isPermaLink="false">5659592</guid>        </item>
        <item>
            <title>Dr Mandeep Mehra leaves Baltimore for post at the Brigham</title>
            <link>http://www.medworm.com/index.php?rid=5647664&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1349427.do</link>
            <description>The accomplished specialist in advanced heart failure is taking on new challenges at the head of the Boston institution's Advanced Heart Disease Center. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647664</comments>
            <pubDate>Wed, 01 Feb 2012 22:15:30 +0100</pubDate>
            <guid isPermaLink="false">5647664</guid>        </item>
        <item>
            <title>&quot;Cardiovascular health,&quot; new focus of the AHA, linked with reduced mortality</title>
            <link>http://www.medworm.com/index.php?rid=5647665&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1349333.do</link>
            <description>Individuals meeting five of seven cardiovascular health metrics outlined by the American Heart Association had a significantly lower risk of all-cause mortality and deaths from diseases of the circulatory system when compared with unhealthy individuals who met none of the cardiovascular health criteria. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647665</comments>
            <pubDate>Wed, 01 Feb 2012 21:15:32 +0100</pubDate>
            <guid isPermaLink="false">5647665</guid>        </item>
        <item>
            <title>US &quot;roadmap&quot; for TAVI rollout published</title>
            <link>http://www.medworm.com/index.php?rid=5647666&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1349137.do</link>
            <description>A new US expert-consensus document on transcatheter aortic-valve implantation aims to smooth the rollout of this new technology stateside. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647666</comments>
            <pubDate>Wed, 01 Feb 2012 20:00:32 +0100</pubDate>
            <guid isPermaLink="false">5647666</guid>        </item>
        <item>
            <title>Restenosis similar with carotid stenting or surgery: CREST</title>
            <link>http://www.medworm.com/index.php?rid=5647667&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1349103.do</link>
            <description>At two years, carotid restenosis is infrequent and appears similar whether patients were treated with carotid stenting or endarterectomy. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647667</comments>
            <pubDate>Wed, 01 Feb 2012 18:30:07 +0100</pubDate>
            <guid isPermaLink="false">5647667</guid>        </item>
        <item>
            <title>Stroke risk linked to infections in children</title>
            <link>http://www.medworm.com/index.php?rid=5647668&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348767.do</link>
            <description>A new study finds the risk is highest closer to infection, then tapers off. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647668</comments>
            <pubDate>Wed, 01 Feb 2012 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647668</guid>        </item>
        <item>
            <title>Combination type 2 diabetes pill gets FDA nod</title>
            <link>http://www.medworm.com/index.php?rid=5647669&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348729.do</link>
            <description>The new treatment option combines linagliptin and metformin in a single tablet taken twice daily in adults with type 2 diabetes who require more than one medication to lower blood glucose. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647669</comments>
            <pubDate>Tue, 31 Jan 2012 22:30:37 +0100</pubDate>
            <guid isPermaLink="false">5647669</guid>        </item>
        <item>
            <title>Shifty and dangerous: Worsening diastolic dysfunction ups mortality</title>
            <link>http://www.medworm.com/index.php?rid=5647670&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348635.do</link>
            <description>Actually, it was just as strong a mortality predictor as worsening systolic function in a retrospective series of patients followed with echocardiography. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647670</comments>
            <pubDate>Tue, 31 Jan 2012 21:45:13 +0100</pubDate>
            <guid isPermaLink="false">5647670</guid>        </item>
        <item>
            <title>&quot;Valve-on-a-stick&quot; transaortic TAVI offers alternative to transfemoral route</title>
            <link>http://www.medworm.com/index.php?rid=5647671&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348519.do</link>
            <description>A growing number of centers, especially in Europe, are trying a third route for transcatheter valve implants in select patients. Instead of threading the device from the femoral artery or up through the left ventricular apex, they're deploying it directly through the aorta. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647671</comments>
            <pubDate>Tue, 31 Jan 2012 20:15:50 +0100</pubDate>
            <guid isPermaLink="false">5647671</guid>        </item>
        <item>
            <title>New data will shed light on cancer risk from imaging</title>
            <link>http://www.medworm.com/index.php?rid=5647672&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348427.do</link>
            <description>Ongoing epidemiological studies in children who have undergone CT scans should help provide a better understanding of radiation-associated cancer risks from cardiac imaging over the next few years. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647672</comments>
            <pubDate>Tue, 31 Jan 2012 18:00:29 +0100</pubDate>
            <guid isPermaLink="false">5647672</guid>        </item>
        <item>
            <title>Dr Robert Harrington leaves DCRI for Stanford University</title>
            <link>http://www.medworm.com/index.php?rid=5647673&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1347937.do</link>
            <description>UPDATED // Dr Robert Harrington has been named the chair of the department of medicine at Stanford University and will be leaving Duke University, where he has worked for the past 22 years. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647673</comments>
            <pubDate>Tue, 31 Jan 2012 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647673</guid>        </item>
        <item>
            <title>PARTNER CAP data show transapical outcomes improve with practice</title>
            <link>http://www.medworm.com/index.php?rid=5647674&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348117.do</link>
            <description>Only 104 of the 799 high-risk patients in the PARTNER A trial of the Sapien transcatheter valve were treated with the transapical approach, so it can be considered to be only the preliminary experience with this technique. Now data from 822 patients in the continued-access protocol are available. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647674</comments>
            <pubDate>Tue, 31 Jan 2012 15:15:37 +0100</pubDate>
            <guid isPermaLink="false">5647674</guid>        </item>
        <item>
            <title>SYNTAX, FAME trials influence update to PCI/CABG appropriate-use criteria</title>
            <link>http://www.medworm.com/index.php?rid=5647675&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1348019.do</link>
            <description>The document somewhat expands the appropriateness of PCI in some patients with left main coronary disease, among other indications. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647675</comments>
            <pubDate>Mon, 30 Jan 2012 22:35:39 +0100</pubDate>
            <guid isPermaLink="false">5647675</guid>        </item>
        <item>
            <title>Once-weekly exenatide okayed by FDA for type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=5647676&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1347905.do</link>
            <description>The FDA approved the once-weekly version of exenatide for type 2 diabetes with a list of required postmarketing studies on the potential for cardiovascular events and medullary thyroid carcinoma. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647676</comments>
            <pubDate>Mon, 30 Jan 2012 22:30:00 +0100</pubDate>
            <guid isPermaLink="false">5647676</guid>        </item>
        <item>
            <title>Statins reduce cardiovascular events and all-cause mortality in women: Meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5647678&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1347045.do</link>
            <description>Based on the meta-analysis, which included 18 clinical trials, investigators conclude that the benefits of statin therapy for the reduction of cardiovascular outcomes and all-cause mortality extend to both men and women. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647678</comments>
            <pubDate>Mon, 30 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647678</guid>        </item>
        <item>
            <title>Women do better after TAVI, hints small study</title>
            <link>http://www.medworm.com/index.php?rid=5647677&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1345445.do</link>
            <description>The first foray into possible gender differences in presentation and outcome among patients undergoing TAVI for severe aortic stenosis hints that women may fare better than men after this procedure. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647677</comments>
            <pubDate>Mon, 30 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647677</guid>        </item>
        <item>
            <title>ASCERT: Better survival for CABG vs PCI in some high-risk patients</title>
            <link>http://www.medworm.com/index.php?rid=5647679&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1346525.do</link>
            <description>The ASCERT study, a unique collaboration between the CMS, ACC, and STS, compares survival rates with bypass surgery and PCI in over 190 000 patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647679</comments>
            <pubDate>Mon, 30 Jan 2012 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647679</guid>        </item>
        <item>
            <title>Interarm BP differences increase CVD risk</title>
            <link>http://www.medworm.com/index.php?rid=5647680&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1346597.do</link>
            <description>New research indicates that large differences in systolic blood pressure between the right and left arm of 15 mm Hg or more point to an increased risk of cardiovascular disease and death. The findings should add weight to guidelines, which already encourage doctors to measure BP in both arms, say the authors and editorialists. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647680</comments>
            <pubDate>Mon, 30 Jan 2012 18:15:56 +0100</pubDate>
            <guid isPermaLink="false">5647680</guid>        </item>
        <item>
            <title>3B or not 3B? Should patients get an LVAD before reaching end-stage HF?</title>
            <link>http://www.medworm.com/index.php?rid=5647681&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1346043.do</link>
            <description>Experts debated the evidence supporting the expansion of LVAD therapy to patients whose heart failure has not yet progressed to the so-called end stage. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647681</comments>
            <pubDate>Mon, 30 Jan 2012 15:00:01 +0100</pubDate>
            <guid isPermaLink="false">5647681</guid>        </item>
        <item>
            <title>Surgeons insist TAVI reimbursement rollout won't be repeat of carotid-stenting debacle</title>
            <link>http://www.medworm.com/index.php?rid=5647682&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1345913.do</link>
            <description>Now that the FDA has approved a transcatheter aortic valve, cardiac surgeons and cardiologists are working together to put all of their ducks in a row to secure national Medicare coverage for the procedure. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647682</comments>
            <pubDate>Mon, 30 Jan 2012 14:00:55 +0100</pubDate>
            <guid isPermaLink="false">5647682</guid>        </item>
        <item>
            <title>Heart disease risk begins with middle-age risk factors</title>
            <link>http://www.medworm.com/index.php?rid=5628381&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1344241.do</link>
            <description>Risk-factor-reduction efforts are usually based on short-term risk scores, but most Americans at low risk for cardiovascular disease over the next 10 years are actually at much higher risk for heart problems over the rest of their lives. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628381</comments>
            <pubDate>Wed, 25 Jan 2012 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628381</guid>        </item>
        <item>
            <title>Cardiologists flagging woeful patient care say they paid with their jobs</title>
            <link>http://www.medworm.com/index.php?rid=5628382&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1341955.do</link>
            <description>An echocardiographer and cardiac surgeon who say their jobs were axed in retaliation after they lodged numerous complaints of substandard patient care at a county hospital in Santa Clara are suing some of their former bosses, including two other cardiologists. The plaintiffs also claim they suffered severe harassment as a result of expressing their concerns. The defendants' attorney says the case &quot;is hotly disputed.&quot; (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628382</comments>
            <pubDate>Wed, 25 Jan 2012 20:30:00 +0100</pubDate>
            <guid isPermaLink="false">5628382</guid>        </item>
        <item>
            <title>Vytorin US label updated with SHARP results</title>
            <link>http://www.medworm.com/index.php?rid=5628383&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1344069.do</link>
            <description>But the FDA has not allowed an official indication for chronic-kidney-disease patients, which has concerned investigators who conducted the trial. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628383</comments>
            <pubDate>Wed, 25 Jan 2012 17:05:17 +0100</pubDate>
            <guid isPermaLink="false">5628383</guid>        </item>
        <item>
            <title>Riata Summit insights: Vigilance key to following functional but &quot;recalled&quot; ICD leads</title>
            <link>http://www.medworm.com/index.php?rid=5628384&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343857.do</link>
            <description>Most attending the recent Riata ICD lead summit felt that fluoroscopic screening of Riata recipients was a reasonable thing to do, at odds with some recommendations. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628384</comments>
            <pubDate>Wed, 25 Jan 2012 15:00:32 +0100</pubDate>
            <guid isPermaLink="false">5628384</guid>        </item>
        <item>
            <title>Pay for SGR repeal with war savings, say medical groups</title>
            <link>http://www.medworm.com/index.php?rid=5628385&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343723.do</link>
            <description>A letter to Rep Dave Camp from 110 medical societies admits that war savings from military pullbacks are a &quot;budget gimmick&quot; but says they could retire SGR debt, another budget gimmick. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628385</comments>
            <pubDate>Tue, 24 Jan 2012 20:45:34 +0100</pubDate>
            <guid isPermaLink="false">5628385</guid>        </item>
        <item>
            <title>Black tea lowers blood pressure in small trial</title>
            <link>http://www.medworm.com/index.php?rid=5628386&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343661.do</link>
            <description>Three daily cups, which provided approximately 400 mg/day of polyphenols, reduced systolic and diastolic blood pressure between 2 to 3 mm Hg, according to researchers. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628386</comments>
            <pubDate>Tue, 24 Jan 2012 20:15:06 +0100</pubDate>
            <guid isPermaLink="false">5628386</guid>        </item>
        <item>
            <title>PLATO: PPI analysis &quot;raises flag&quot; but should not change practice</title>
            <link>http://www.medworm.com/index.php?rid=5628387&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343601.do</link>
            <description>A new analysis of the PLATO study has found that use of a proton-pump inhibitor was independently associated with a higher rate of cardiovascular events but that this was apparent in both the ticagrelor and clopidogrel arms. The finding is likely due to confounding and should not precipitate any change in advice on this subject, says the lead author. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628387</comments>
            <pubDate>Tue, 24 Jan 2012 18:00:47 +0100</pubDate>
            <guid isPermaLink="false">5628387</guid>        </item>
        <item>
            <title>Carotid images don't boost quit rates or cut CV risk factors in smokers</title>
            <link>http://www.medworm.com/index.php?rid=5628388&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343401.do</link>
            <description>A new randomized controlled trial is the latest addition to a contentious field of research trying to establish whether &quot;seeing is believing&quot; when it comes to motivating cardiovascular risk reduction. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628388</comments>
            <pubDate>Mon, 23 Jan 2012 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628388</guid>        </item>
        <item>
            <title>Cardiologists accused of defrauding Medicare by performing unnecessary cardiac procedures</title>
            <link>http://www.medworm.com/index.php?rid=5628389&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343363.do</link>
            <description>A new whistle-blower lawsuit filed in US District Court claims that five cardiologists from two medical practices in Erie, PA defrauded Medicare by performing unnecessary cardiac and vascular surgeries and interventional procedures between 2001 and 2005. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628389</comments>
            <pubDate>Mon, 23 Jan 2012 21:30:18 +0100</pubDate>
            <guid isPermaLink="false">5628389</guid>        </item>
        <item>
            <title>Gifts, pep talks have some success post-PCI and in hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5628390&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343087.do</link>
            <description>Some of the first research showing that positive affect interventions&amp;#x2014;including phone calls to bolster self-affirming thoughts and small gifts&amp;#x2014;generate some success in post-PCI and hypertensive patients has been published. An editorialist describes the work as &quot;innovative&quot; and calls for many more studies of this kind. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628390</comments>
            <pubDate>Mon, 23 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5628390</guid>        </item>
        <item>
            <title>To prescribe or not to prescribe: That is the statin question, experts debate</title>
            <link>http://www.medworm.com/index.php?rid=5628391&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1343169.do</link>
            <description>The two very different sides of the statin argument are debated today in the Wall Street Journal, with Dr Roger Blumenthal arguing the drugs prevent heart disease in patients with cardiovascular risk factors as well as in those who have already had a cardiovascular event. Dr Rita Redberg, on the other hand, argues against the current practice of prescribing statins to healthy patients with cardiovascular risk factors, including individuals with elevated cholesterol levels. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5628391</comments>
            <pubDate>Mon, 23 Jan 2012 17:30:09 +0100</pubDate>
            <guid isPermaLink="false">5628391</guid>        </item>
        <item>
            <title>Dapagliflozin declined by FDA</title>
            <link>http://www.medworm.com/index.php?rid=5608622&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342425.do</link>
            <description>The US Food and Drug Administration has denied approval for the novel diabetes drug dapagliflozin, asking codevelopers Bristol-Myers Squibb and AstraZeneca to provide more studies. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608622</comments>
            <pubDate>Thu, 19 Jan 2012 22:00:54 +0100</pubDate>
            <guid isPermaLink="false">5608622</guid>        </item>
        <item>
            <title>Lower mortality rates at two years with transradial PCI, Italian registry shows</title>
            <link>http://www.medworm.com/index.php?rid=5608623&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342405.do</link>
            <description>In a propensity-score-matching analysis, the mortality rate at two years was 8.8% among patients treated via the radial artery and 11.4% in the femoral-PCI patients, a statistically significance difference. Transradial PCI was also associated with a significantly reduced need for vascular surgery and blood transfusions. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608623</comments>
            <pubDate>Thu, 19 Jan 2012 21:45:25 +0100</pubDate>
            <guid isPermaLink="false">5608623</guid>        </item>
        <item>
            <title>Pillow talk: First AHA advice on sex and CVD</title>
            <link>http://www.medworm.com/index.php?rid=5608624&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342371.do</link>
            <description>The first-ever guidance on sexual activity and cardiovascular disease from the AHA encourages doctors, patients, and their partners to discuss the subject during consultations. The majority of those with heart disease can safely engage in sex, which is important to quality of life, it concludes. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608624</comments>
            <pubDate>Thu, 19 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608624</guid>        </item>
        <item>
            <title>Treat risk and not LDL-cholesterol targets, new perspective argues</title>
            <link>http://www.medworm.com/index.php?rid=5608625&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342317.do</link>
            <description>In focusing on patient risk, rather than LDL-cholesterol treatment targets, doctors would improve patient outcomes and reduce adverse effects and costs that result from treating low-risk, low-benefit patients, say experts. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608625</comments>
            <pubDate>Thu, 19 Jan 2012 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608625</guid>        </item>
        <item>
            <title>&quot;High-normal&quot; blood pressure linked to AF</title>
            <link>http://www.medworm.com/index.php?rid=5608626&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342189.do</link>
            <description>Upper-normal levels of blood pressure in otherwise-healthy middle-aged men appear to predict a higher risk for the development of atrial fibrillation in older age, a new study suggests. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608626</comments>
            <pubDate>Wed, 18 Jan 2012 22:15:44 +0100</pubDate>
            <guid isPermaLink="false">5608626</guid>        </item>
        <item>
            <title>New AF ablation programs need time, money, and data</title>
            <link>http://www.medworm.com/index.php?rid=5608627&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342079.do</link>
            <description>Starting up an atrial fibrillation ablation program takes more than just a couple of skilled electrophysiologists, Dr Rodney Horton explained at the Boston Atrial Fibrillation Symposium. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608627</comments>
            <pubDate>Wed, 18 Jan 2012 20:00:06 +0100</pubDate>
            <guid isPermaLink="false">5608627</guid>        </item>
        <item>
            <title>FFR shows benefit in FAME II; enrollment halted</title>
            <link>http://www.medworm.com/index.php?rid=5608628&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1342001.do</link>
            <description>An interim analysis of the FAME II study shows a significant benefit of fractional-flow-reserve-guided stenting plus optimal medical therapy over and above optimal medical therapy alone; as a result the data safety monitoring board has said no further patients should be randomized to medical therapy alone. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608628</comments>
            <pubDate>Wed, 18 Jan 2012 17:00:29 +0100</pubDate>
            <guid isPermaLink="false">5608628</guid>        </item>
        <item>
            <title>Mortality climbs with rising PA pressure in heart failure: Community-based study</title>
            <link>http://www.medworm.com/index.php?rid=5608629&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1341869.do</link>
            <description>The finding in a broad community-based HF population confirms and extends what is recognized in the hospital setting. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608629</comments>
            <pubDate>Wed, 18 Jan 2012 14:45:46 +0100</pubDate>
            <guid isPermaLink="false">5608629</guid>        </item>
        <item>
            <title>BRIDGE study published: Cangrelor suited for important antiplatelet niche</title>
            <link>http://www.medworm.com/index.php?rid=5608631&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1341135.do</link>
            <description>The intravenous antiplatelet with a very short half-life is the ideal candidate for bridging patients on clopidogrel or other thienopyridines to surgery, the authors say. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608631</comments>
            <pubDate>Tue, 17 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608631</guid>        </item>
        <item>
            <title>Contemporary look at VTE after joint surgery</title>
            <link>http://www.medworm.com/index.php?rid=5608630&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340807.do</link>
            <description>One in 100 patients who have knee-replacement surgery and one in 200 who undergo hip replacement will have a venous thromboembolic event in the hospital, despite receiving modern anticoagulant prophylaxis, a new review shows. These numbers will help inform patients and clinicians, say the authors, but an editorialist notes that to get a better picture, it will be necessary to look at a longer postsurgery time frame. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608630</comments>
            <pubDate>Tue, 17 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5608630</guid>        </item>
        <item>
            <title>NHANES: One in three adults, one in six children obese</title>
            <link>http://www.medworm.com/index.php?rid=5608632&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1341235.do</link>
            <description>Obesity continues to be a significant public health problem in the US, affecting more than one-third of US adults and 17% of children and adolescents, but 2009-2010 data suggest trends may have plateaued for most groups. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608632</comments>
            <pubDate>Tue, 17 Jan 2012 18:00:04 +0100</pubDate>
            <guid isPermaLink="false">5608632</guid>        </item>
        <item>
            <title>Dronedarone gets another chance to prove itself in ranolazine combo trial</title>
            <link>http://www.medworm.com/index.php?rid=5597336&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340897.do</link>
            <description>Researchers of the beleaguered antiarrhythmic dronedarone believe the drug may still have a role to play in AF therapy for some patients and are testing it as a low-dose compliment to another newer antiarrhythmic drug, ranolazine. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597336</comments>
            <pubDate>Mon, 16 Jan 2012 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5597336</guid>        </item>
        <item>
            <title>CCTA is less useful in patients with high calcium score</title>
            <link>http://www.medworm.com/index.php?rid=5597337&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340873.do</link>
            <description>The diagnostic accuracy of any test depends largely on disease prevalence in the tested population. CORE-64 researchers looked at how calcium scores could help identify patients with such a high likelihood of disease that CCTA is not useful. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597337</comments>
            <pubDate>Mon, 16 Jan 2012 21:15:00 +0100</pubDate>
            <guid isPermaLink="false">5597337</guid>        </item>
        <item>
            <title>Thoracic endoprosthesis gets traumatic transection approval</title>
            <link>http://www.medworm.com/index.php?rid=5597338&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340707.do</link>
            <description>The FDA has expanded approval for the Gore TAG Thoracic Endoprosthesis to include treatment of &quot;life-threatening tears or ruptures of the aorta.&quot; (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597338</comments>
            <pubDate>Mon, 16 Jan 2012 16:30:00 +0100</pubDate>
            <guid isPermaLink="false">5597338</guid>        </item>
        <item>
            <title>New AF ablation consensus doc previewed at Boston AF symposium</title>
            <link>http://www.medworm.com/index.php?rid=5597339&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340417.do</link>
            <description>A group of 45 AF experts from North America and Europe will soon publish a major update to the 2007 international clinical consensus statement for the use of catheter and surgical ablation for the treatment of AF. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597339</comments>
            <pubDate>Sat, 14 Jan 2012 00:30:00 +0100</pubDate>
            <guid isPermaLink="false">5597339</guid>        </item>
        <item>
            <title>Resveratrol scientists react to Das fraud scandal: &quot;Research will continue&quot;</title>
            <link>http://www.medworm.com/index.php?rid=5597340&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340357.do</link>
            <description>As the controversy over the research fraud allegations against Dr Dipak Das enters its third day, researchers told heartwire what the news means for the field of resveratrol research and, more pressingly, an upcoming scientific meeting. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597340</comments>
            <pubDate>Fri, 13 Jan 2012 22:20:01 +0100</pubDate>
            <guid isPermaLink="false">5597340</guid>        </item>
        <item>
            <title>Yoga therapy for AF yields insight into brain-heart axis</title>
            <link>http://www.medworm.com/index.php?rid=5597341&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340075.do</link>
            <description>Yoga has shown to help some patients manage atrial fibrillation, so researchers are moving forward with investigations of yoga's influence on cardiac autonomics to better understand the biology of meditative practice. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597341</comments>
            <pubDate>Fri, 13 Jan 2012 16:10:43 +0100</pubDate>
            <guid isPermaLink="false">5597341</guid>        </item>
        <item>
            <title>FDA: CardioGen-82 problems site-specific</title>
            <link>http://www.medworm.com/index.php?rid=5597342&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1340045.do</link>
            <description>The generators, used in cardiac nuclear scans, were recalled by the manufacturer last summer, and the FDA previously found fault with manufacturing processes. Now the FDA says the excessive radiation cases appear to have occurred only at specific clinical sites and were unrelated to any manufacturing deficiencies. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597342</comments>
            <pubDate>Fri, 13 Jan 2012 15:15:04 +0100</pubDate>
            <guid isPermaLink="false">5597342</guid>        </item>
        <item>
            <title>Red-wine researcher charged with photo-editing fraud</title>
            <link>http://www.medworm.com/index.php?rid=5597343&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339923.do</link>
            <description>A University of Connecticut investigation found Dr Dipak K Das guilty of falsifying and fabricating images that appeared in published research. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5597343</comments>
            <pubDate>Fri, 13 Jan 2012 14:30:31 +0100</pubDate>
            <guid isPermaLink="false">5597343</guid>        </item>
        <item>
            <title>US bleeding ADRs higher with dabigatran than warfarin</title>
            <link>http://www.medworm.com/index.php?rid=5581356&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339775.do</link>
            <description>There is particular concern over use of dabigatran in the elderly, in whom there has been a high number of bleeds, including intracranial hemorrhages, reported to the FDA. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581356</comments>
            <pubDate>Thu, 12 Jan 2012 20:40:19 +0100</pubDate>
            <guid isPermaLink="false">5581356</guid>        </item>
        <item>
            <title>Silent atrial fibrillation increases stroke risk</title>
            <link>http://www.medworm.com/index.php?rid=5581357&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339579.do</link>
            <description>A new study finds device-detected atrial tachyarrhythmias occur frequently and are associated with a significant increase in risk for stroke and systemic embolism. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581357</comments>
            <pubDate>Thu, 12 Jan 2012 13:15:50 +0100</pubDate>
            <guid isPermaLink="false">5581357</guid>        </item>
        <item>
            <title>Very low risk of cardiac arrest and sudden death in long-distance running events</title>
            <link>http://www.medworm.com/index.php?rid=5581358&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339541.do</link>
            <description>Despite the high-profile deaths of seemingly healthy runners at marathons in the past few years, new data show that the risk of cardiac arrest and sudden death during marathon and half-marathon running races is actually quite low. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581358</comments>
            <pubDate>Wed, 11 Jan 2012 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581358</guid>        </item>
        <item>
            <title>Statins cost four times more in US than UK</title>
            <link>http://www.medworm.com/index.php?rid=5581359&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339515.do</link>
            <description>UPDATED // Based on 2005 numbers, American private insurers paid as much as 400% more for statins than the UK government was paying over the same period. Even for statins sold as brand-name drugs in both countries, US costs were at least double. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581359</comments>
            <pubDate>Wed, 11 Jan 2012 20:00:38 +0100</pubDate>
            <guid isPermaLink="false">5581359</guid>        </item>
        <item>
            <title>Inactivity is a universal risk factor for heart attack</title>
            <link>http://www.medworm.com/index.php?rid=5581360&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339481.do</link>
            <description>New findings from the INTERHEART study show that being physically active during leisure and work time protects against MI. The message is simple, say the authors: incorporate as much physical activity into daily life as is possible. Not surprisingly, those who own a TV and car have a higher risk of MI, they also show. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581360</comments>
            <pubDate>Wed, 11 Jan 2012 17:40:42 +0100</pubDate>
            <guid isPermaLink="false">5581360</guid>        </item>
        <item>
            <title>Pulmonary hypertension in kids differs from adult PAH</title>
            <link>http://www.medworm.com/index.php?rid=5581361&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338709.do</link>
            <description>A new registry of children with pulmonary hypertension is helping to differentiate the pediatric population with this disease from the adult one and should aid in better diagnosis and treatment of this condition in kids, say the authors. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581361</comments>
            <pubDate>Tue, 10 Jan 2012 23:30:00 +0100</pubDate>
            <guid isPermaLink="false">5581361</guid>        </item>
        <item>
            <title>Venous thrombosis, pulmonary embolism raise mortality risk</title>
            <link>http://www.medworm.com/index.php?rid=5581362&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1339083.do</link>
            <description>First-time venous thrombosis or pulmonary embolism dramatically increases the long-term mortality rate in individuals with and without malignancy, according to a recent study. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581362</comments>
            <pubDate>Tue, 10 Jan 2012 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581362</guid>        </item>
        <item>
            <title>GWTG improves AMI care in Asian Americans</title>
            <link>http://www.medworm.com/index.php?rid=5581364&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338979.do</link>
            <description>The new data suggest that among participating hospitals in the GWTG program, equitable quality care for many performance measures can be attained across racial and ethnic groups, including Asian Americans, say researchers. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581364</comments>
            <pubDate>Tue, 10 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581364</guid>        </item>
        <item>
            <title>Serum potassium targets in acute MI need rethink, analysis suggests</title>
            <link>http://www.medworm.com/index.php?rid=5581363&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338913.do</link>
            <description>Recommendations to routinely raise serum potassium levels when ventricular arrhythmias are a concern may be based on outmoded data, according to authors of one of the largest analyses of its kind. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581363</comments>
            <pubDate>Tue, 10 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581363</guid>        </item>
        <item>
            <title>New DES best older stents for deaths, restenosis in latest SCAAR data</title>
            <link>http://www.medworm.com/index.php?rid=5581365&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338837.do</link>
            <description>The latest data from the Swedish registry that launched the international furor over stent thrombosis with drug-eluting stents is now providing reassuring data about the safety and efficacy of the latest generation of the devices. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581365</comments>
            <pubDate>Tue, 10 Jan 2012 20:00:18 +0100</pubDate>
            <guid isPermaLink="false">5581365</guid>        </item>
        <item>
            <title>Aspirin in primary prevention: New meta-analysis finds bleeding outweighs benefits for most</title>
            <link>http://www.medworm.com/index.php?rid=5581366&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338803.do</link>
            <description>But there may be a case for aspirin treatment in certain individuals at high risk of heart disease or with a family history of cancer. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581366</comments>
            <pubDate>Tue, 10 Jan 2012 19:00:46 +0100</pubDate>
            <guid isPermaLink="false">5581366</guid>        </item>
        <item>
            <title>New guidelines suggest blood glucose testing for all inpatients</title>
            <link>http://www.medworm.com/index.php?rid=5581367&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338637.do</link>
            <description>New clinical-practice guidelines from the Endocrine Society say all patients should have a glucose test on admission to the hospital and describe optimal management of hyperglycemia in patients who do not require intensive care. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581367</comments>
            <pubDate>Tue, 10 Jan 2012 14:30:37 +0100</pubDate>
            <guid isPermaLink="false">5581367</guid>        </item>
        <item>
            <title>Aortic stenosis grading system misses rare, high-risk group</title>
            <link>http://www.medworm.com/index.php?rid=5581368&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338543.do</link>
            <description>A new study has examined the clinical outcomes of asymptomatic aortic-stenosis patients classified by valve area plus flow-gradient patterns instead of the older, inherently inconsistent system based on separate area, gradient, and flow measurements. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581368</comments>
            <pubDate>Mon, 09 Jan 2012 22:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581368</guid>        </item>
        <item>
            <title>Statin use associated with significantly increased risk of diabetes: WHI analysis</title>
            <link>http://www.medworm.com/index.php?rid=5581371&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338497.do</link>
            <description>New data from the Women's Health Initiative hint that the risk of diabetes is higher than suggested by previous studies, with investigators reporting a 48% increased risk of diabetes among women taking the lipid-lowering medications. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581371</comments>
            <pubDate>Mon, 09 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581371</guid>        </item>
        <item>
            <title>Bereavement triggers MI, new study finds</title>
            <link>http://www.medworm.com/index.php?rid=5581370&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338371.do</link>
            <description>Bereaved people are 21 times more likely to suffer an MI the day after the death of a significant other, and this heightened risk remains for as long as a month afterward, new research finds. Healthcare providers, the bereaved themselves, and their family and friends need to recognize this heightened risk, say the authors. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581370</comments>
            <pubDate>Mon, 09 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581370</guid>        </item>
        <item>
            <title>Dabigatran: New data on MI and ischemic events</title>
            <link>http://www.medworm.com/index.php?rid=5581369&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338427.do</link>
            <description>The question of MI risk with dabigatran is in the spotlight once again, with two new papers on the subject published within the last few days. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581369</comments>
            <pubDate>Mon, 09 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5581369</guid>        </item>
        <item>
            <title>UK's NICE wants more data on rivaroxaban in AF</title>
            <link>http://www.medworm.com/index.php?rid=5581372&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1338285.do</link>
            <description>The UK drugs cost-efficacy watchdog, NICE, has asked for more data from Bayer before it will sanction use of rivaroxaban for stroke prevention in atrial-fibrillation patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581372</comments>
            <pubDate>Mon, 09 Jan 2012 15:50:00 +0100</pubDate>
            <guid isPermaLink="false">5581372</guid>        </item>
        <item>
            <title>Informed consent questioned in Florida patient's death after stem-cell treatment</title>
            <link>http://www.medworm.com/index.php?rid=5572076&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1337445.do</link>
            <description>A Florida cardiologist is accused of malpractice after a patient treated with a novel stem-cell therapy died of a brain infarct. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572076</comments>
            <pubDate>Fri, 06 Jan 2012 19:15:42 +0100</pubDate>
            <guid isPermaLink="false">5572076</guid>        </item>
        <item>
            <title>MitraClip: Encouraging results in nonsurgical patients</title>
            <link>http://www.medworm.com/index.php?rid=5572077&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1337321.do</link>
            <description>While the clip did appear to reduce mitral regurgitation and improve remodeling in patients unsuitable for surgery in the EVEREST II trial, problems with the comparator group make the results difficult to interpret. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572077</comments>
            <pubDate>Fri, 06 Jan 2012 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">5572077</guid>        </item>
        <item>
            <title>Complications, rehospitalizations not uncommon post-AF ablation</title>
            <link>http://www.medworm.com/index.php?rid=5572078&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1337295.do</link>
            <description>Little is known about the complication rates for atrial fibrillation outside of academic hospitals and Medicare data, so researchers in California analyzed data from a state database to estimate the complication risk of AF ablation in the contemporary community setting. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572078</comments>
            <pubDate>Thu, 05 Jan 2012 22:15:45 +0100</pubDate>
            <guid isPermaLink="false">5572078</guid>        </item>
        <item>
            <title>Novel LDL-gene-targeted agent promising</title>
            <link>http://www.medworm.com/index.php?rid=5572079&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1337093.do</link>
            <description>Suppressing the activity of PCSK9, a gene known to mediate low-density-lipoprotein cholesterol metabolism, cut LDL-C levels in a small dose-ranging study. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572079</comments>
            <pubDate>Thu, 05 Jan 2012 19:45:54 +0100</pubDate>
            <guid isPermaLink="false">5572079</guid>        </item>
        <item>
            <title>Excess calories, not proportion of dietary protein, key in causing obesity</title>
            <link>http://www.medworm.com/index.php?rid=5581373&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1336701.do</link>
            <description>Excessive food intake, rather than the mix of protein, fat, and carbohydrates, has been implicated in causing obesity and is key in treating it. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5581373</comments>
            <pubDate>Thu, 05 Jan 2012 15:15:33 +0100</pubDate>
            <guid isPermaLink="false">5581373</guid>        </item>
        <item>
            <title>Calories, not protein, fat, carbs, key in causing obesity</title>
            <link>http://www.medworm.com/index.php?rid=5572080&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1336701.do</link>
            <description>Excessive food intake, rather than the mix of protein, fat, and carbohydrates, has been implicated in causing obesity and is key in treating it. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572080</comments>
            <pubDate>Thu, 05 Jan 2012 15:15:33 +0100</pubDate>
            <guid isPermaLink="false">5572080</guid>        </item>
        <item>
            <title>RESPECT PFO/stroke trial completes enrollment</title>
            <link>http://www.medworm.com/index.php?rid=5572081&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1336655.do</link>
            <description>After eight years of sluggish patient accrual, the RESPECT trial looking at the Amplatzer device for the prevention of cryptogenic stroke has finally collected enough events for the trial to be stopped. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572081</comments>
            <pubDate>Wed, 04 Jan 2012 22:00:32 +0100</pubDate>
            <guid isPermaLink="false">5572081</guid>        </item>
        <item>
            <title>Public Citizen requests recall of the Wingspan stent</title>
            <link>http://www.medworm.com/index.php?rid=5572082&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1336533.do</link>
            <description>A consumer-advocacy group argues that the Wingspan Stent System provides less benefit and causes more harm than aggressive medical treatment alone. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572082</comments>
            <pubDate>Wed, 04 Jan 2012 21:15:25 +0100</pubDate>
            <guid isPermaLink="false">5572082</guid>        </item>
        <item>
            <title>BRCA1 cancer gene affects cardiac function</title>
            <link>http://www.medworm.com/index.php?rid=5572083&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1336075.do</link>
            <description>Canadian researchers have discovered that the BRCA1 gene is implicated in cardiac function, at least in mice. The findings may also have implications for cancer sufferers who have mutations in this gene: they may be at increased risk of heart disease and more likely to suffer cardiotoxicity from chemotherapy. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5572083</comments>
            <pubDate>Wed, 04 Jan 2012 19:00:00 +0100</pubDate>
            <guid isPermaLink="false">5572083</guid>        </item>
        <item>
            <title>Rivaroxaban filed for ACS in US and EU</title>
            <link>http://www.medworm.com/index.php?rid=5559780&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1335395.do</link>
            <description>The factor Xa inhibitor rivaroxaban has been filed for approval for the additional indication of secondary prevention in acute coronary syndrome in both the US and EU. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559780</comments>
            <pubDate>Wed, 04 Jan 2012 14:30:58 +0100</pubDate>
            <guid isPermaLink="false">5559780</guid>        </item>
        <item>
            <title>Type 2 diabetes adds risk to tissue valves</title>
            <link>http://www.medworm.com/index.php?rid=5559781&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1335311.do</link>
            <description>Type 2 diabetes is a known determinant of degeneration of both native and prosthetic valve implants, so a group of Italian researchers investigated whether bioprosthetic valves also degenerate faster in diabetic patients vs nondiabetic patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559781</comments>
            <pubDate>Tue, 03 Jan 2012 22:15:47 +0100</pubDate>
            <guid isPermaLink="false">5559781</guid>        </item>
        <item>
            <title>US leads in shorter hospital stays, early readmission after STEMI</title>
            <link>http://www.medworm.com/index.php?rid=5559783&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1335271.do</link>
            <description>Patients with ST-segment-elevation MI were more likely to be hospitalized again within a month if they had been treated in the US, and American patients had the shortest initial hospitalization, in a retrospective study of data from an international trial. The work identifies national differences in this measure of care&amp;#x2014;30-day-readmission&amp;#x2014;and it should help guide future investigations, the authors say. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559783</comments>
            <pubDate>Tue, 03 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5559783</guid>        </item>
        <item>
            <title>Bariatric surgery reduces CV events, but mechanisms remain a mystery</title>
            <link>http://www.medworm.com/index.php?rid=5559782&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1335223.do</link>
            <description>The latest data from the Swedish Obese Subjects study show that bariatric surgery reduces the risk of cardiovascular events and CV death among obese individuals, compared with usual care. But weight loss is not the reason behind this reduced risk, meaning that guidelines that use BMI to determine who will get such surgery need updating, say the authors and an editorialist. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559782</comments>
            <pubDate>Tue, 03 Jan 2012 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5559782</guid>        </item>
        <item>
            <title>Enoxaparin prophylaxis doesn't cut mortality in acute-care setting</title>
            <link>http://www.medworm.com/index.php?rid=5552222&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1334877.do</link>
            <description>Antithrombotic prophylaxis remains important in this group for other reasons, but don't expect it to necessarily prevent death, according to researchers. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552222</comments>
            <pubDate>Fri, 30 Dec 2011 14:00:02 +0100</pubDate>
            <guid isPermaLink="false">5552222</guid>        </item>
        <item>
            <title>Mayo report: It takes docs about 30 TAVIs to achieve proficiency</title>
            <link>http://www.medworm.com/index.php?rid=5552223&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1334797.do</link>
            <description>Two new single-center studies shed light on the contemporary experience with new transcatheter aortic-valve systems. One looks at the &quot;learning curve&quot; required for operators to become proficient with the devices, and the other investigates how patient selection for these procedures has changed over time. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552223</comments>
            <pubDate>Thu, 29 Dec 2011 22:15:00 +0100</pubDate>
            <guid isPermaLink="false">5552223</guid>        </item>
        <item>
            <title>Analysis slams use of clopidogrel loss-of-function gene test; proponents fire back</title>
            <link>http://www.medworm.com/index.php?rid=5552224&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1334629.do</link>
            <description>A new meta-analysis and especially an accompanying editorial argue against current use of CYP2C19 genotyping to define risk of subsequent CV events in patients considered for clopidogrel. Proponents of the test defend its use and describe what they see as flaws in the study. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552224</comments>
            <pubDate>Thu, 29 Dec 2011 20:30:00 +0100</pubDate>
            <guid isPermaLink="false">5552224</guid>        </item>
        <item>
            <title>Troponins at admission and three hours allow MI diagnosis or rule-out</title>
            <link>http://www.medworm.com/index.php?rid=5552225&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1334469.do</link>
            <description>Troponin levels measured using a sensitive or highly sensitive assay can help with early MI rule-out, suggests a study that makes a case supporting the possible approval of the high-sensitivity assay in the US. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552225</comments>
            <pubDate>Wed, 28 Dec 2011 23:30:00 +0100</pubDate>
            <guid isPermaLink="false">5552225</guid>        </item>
        <item>
            <title>Congress postpones Medicare pay cut</title>
            <link>http://www.medworm.com/index.php?rid=5537707&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1333879.do</link>
            <description>UPDATED // After the Senate had overwhelmingly approved the plan and a tumultuous few days among House Republicans, this morning Congress voted to put off a steep cut in Medicare physician reimbursements that was to take effect on January 1, 2012. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537707</comments>
            <pubDate>Fri, 23 Dec 2011 14:30:15 +0100</pubDate>
            <guid isPermaLink="false">5537707</guid>        </item>
        <item>
            <title>MR beats out SPECT in CE-MARC crossover trial</title>
            <link>http://www.medworm.com/index.php?rid=5537708&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1333199.do</link>
            <description>The diagnostic accuracy of SPECT imaging for assessment of myocardial ischemia is variable and exposes patients to ionizing radiation, so evidence that magnetic resonance can be at least as accurate might make it an attractive alternative. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537708</comments>
            <pubDate>Thu, 22 Dec 2011 23:30:00 +0100</pubDate>
            <guid isPermaLink="false">5537708</guid>        </item>
        <item>
            <title>CMS announces DRGs under scrutiny as part of trial prepayment audit program</title>
            <link>http://www.medworm.com/index.php?rid=5537709&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1333623.do</link>
            <description>The recovery audit contractor prepayment program is to be implemented January 2012 in 11 states, including some of the most populous, and will focus first on selected DRGs often associated with claims errors. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537709</comments>
            <pubDate>Thu, 22 Dec 2011 19:45:54 +0100</pubDate>
            <guid isPermaLink="false">5537709</guid>        </item>
        <item>
            <title>European CRT survey bolsters support for CRT-D  over CRT-P</title>
            <link>http://www.medworm.com/index.php?rid=5524454&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1332567.do</link>
            <description>The survey of contemporary European cardiac resynchronization therapy practices provides lots of information on patients not well represented in clinical trials, including those with major comorbidities and women. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524454</comments>
            <pubDate>Wed, 21 Dec 2011 20:30:39 +0100</pubDate>
            <guid isPermaLink="false">5524454</guid>        </item>
        <item>
            <title>Biggest cardiology stories of 2011</title>
            <link>http://www.medworm.com/index.php?rid=5524455&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1329521.do</link>
            <description>What made headlines in 2011? Everything from novel oral anticoagulants, blockbuster trials stopped early, and a new scrutiny on procedure appropriateness. heartwire reporters called up cardiologists across 11 different subspecialties to ask them what they thought the biggest news was in their field this past year. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524455</comments>
            <pubDate>Wed, 21 Dec 2011 17:00:49 +0100</pubDate>
            <guid isPermaLink="false">5524455</guid>        </item>
        <item>
            <title>FDA approves new combination for hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5524456&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1331977.do</link>
            <description>The new agent is the first fixed-dose therapy in the US to combine an angiotensin-receptor blocker with the diuretic chlorthalidone. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524456</comments>
            <pubDate>Wed, 21 Dec 2011 15:45:34 +0100</pubDate>
            <guid isPermaLink="false">5524456</guid>        </item>
        <item>
            <title>First data to show antihypertensive therapy prolongs life</title>
            <link>http://www.medworm.com/index.php?rid=5524457&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1330093.do</link>
            <description>The first-ever long-term data from a high-blood-pressure trial, the Systolic Hypertension in the Elderly Program, reveals that people taking the antihypertensives lived longer free from cardiovascular disease and died less often from CV causes. The results should help encourage patients to comply with medication and doctors to prescribe it, say the researchers. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524457</comments>
            <pubDate>Tue, 20 Dec 2011 21:00:25 +0100</pubDate>
            <guid isPermaLink="false">5524457</guid>        </item>
        <item>
            <title>Increasing heart rate over time linked with heart disease mortality</title>
            <link>http://www.medworm.com/index.php?rid=5524458&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1331477.do</link>
            <description>Despite the adverse effects of an increase in resting heart rate over time, individuals who lowered their resting heart rate did not have a lower risk of ischemic heart disease, a finding that suggests the association is not linear. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524458</comments>
            <pubDate>Tue, 20 Dec 2011 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5524458</guid>        </item>
        <item>
            <title>ALTITUDE halted: Adverse events when aliskiren added to ACE, ARB therapy</title>
            <link>http://www.medworm.com/index.php?rid=5524459&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1331173.do</link>
            <description>Data and safety monitors for ALTITUDE noted that patients in the trial taking aliskiren instead of placebo on top of ACE or ARB therapy experienced an increased incidence of nonfatal stroke, renal complications, hyperkalemia, and hypotension. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524459</comments>
            <pubDate>Tue, 20 Dec 2011 18:20:02 +0100</pubDate>
            <guid isPermaLink="false">5524459</guid>        </item>
        <item>
            <title>Overeating, salt, the real culprits in stroke risk</title>
            <link>http://www.medworm.com/index.php?rid=5524460&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1330409.do</link>
            <description>The quality and quantity of a person's diet are more important determinants of stroke risk than the foods and nutrients consumed. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524460</comments>
            <pubDate>Tue, 20 Dec 2011 15:15:41 +0100</pubDate>
            <guid isPermaLink="false">5524460</guid>        </item>
        <item>
            <title>Improving BP in middle age pays off later</title>
            <link>http://www.medworm.com/index.php?rid=5524461&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1330287.do</link>
            <description>Most studies of lifetime risk of cardiovascular disease that have focused on BP look at one index point, so researchers have examined multiple pooled studies to see how changes in BP over time during middle age affect lifetime risk. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524461</comments>
            <pubDate>Mon, 19 Dec 2011 22:30:20 +0100</pubDate>
            <guid isPermaLink="false">5524461</guid>        </item>
        <item>
            <title>FDA puts new warnings on dronedarone</title>
            <link>http://www.medworm.com/index.php?rid=5524462&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1330259.do</link>
            <description>The FDA is warning atrial-fibrillation patients taking dronedarone about the risks of the drug in patients with permanent AF. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524462</comments>
            <pubDate>Mon, 19 Dec 2011 22:00:31 +0100</pubDate>
            <guid isPermaLink="false">5524462</guid>        </item>
        <item>
            <title>RECOVER II confirms benefit of dabigatran in treatment of VTE</title>
            <link>http://www.medworm.com/index.php?rid=5524463&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1330215.do</link>
            <description>The new study adds another 2500 patients tested with dabigatran in the setting of VTE, confirming the results observed in the first RECOVER study. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524463</comments>
            <pubDate>Mon, 19 Dec 2011 21:45:08 +0100</pubDate>
            <guid isPermaLink="false">5524463</guid>        </item>
        <item>
            <title>Support for edoxaban for VTE prevention</title>
            <link>http://www.medworm.com/index.php?rid=5524464&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1329499.do</link>
            <description>The benefit of edoxaban over enoxaparin for the prevention of VTE following hip and knee surgery did not appear to come at a cost, according to investigators, as there was no statistically significant increased risk in bleeding in the overall cohort or in any subgroups. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524464</comments>
            <pubDate>Mon, 19 Dec 2011 18:00:17 +0100</pubDate>
            <guid isPermaLink="false">5524464</guid>        </item>
        <item>
            <title>FDA approves first pediatric VAD</title>
            <link>http://www.medworm.com/index.php?rid=5524465&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1329483.do</link>
            <description>The FDA has approved the first humanitarian device exemption for a pediatric ventricular assist device. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524465</comments>
            <pubDate>Mon, 19 Dec 2011 17:00:17 +0100</pubDate>
            <guid isPermaLink="false">5524465</guid>        </item>
        <item>
            <title>Rivaroxaban approved in Europe for AF and DVT treatment</title>
            <link>http://www.medworm.com/index.php?rid=5524466&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1329421.do</link>
            <description>The factor Xa oral anticoagulant rivaroxaban has been approved in the European Union for the prevention of nonvalvular AF-related stroke and systemic embolism and for the treatment of DVT. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524466</comments>
            <pubDate>Mon, 19 Dec 2011 15:45:19 +0100</pubDate>
            <guid isPermaLink="false">5524466</guid>        </item>
        <item>
            <title>Combining wireless sensors and genomics for CVD prevention?</title>
            <link>http://www.medworm.com/index.php?rid=5524467&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1329223.do</link>
            <description>Monitoring an individual's risk for MI in the future would ideally first take into account his or her genome sequence or other biomarkers and then might use an implanted nanosensor smaller than a grain of sand. In an excerpt from his new book, The Creative Destruction of Medicine, theheart.org's editor in chief offers a glimpse of what that might look like. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524467</comments>
            <pubDate>Mon, 19 Dec 2011 15:00:31 +0100</pubDate>
            <guid isPermaLink="false">5524467</guid>        </item>
        <item>
            <title>Hospital admissions predict readmission for heart failure</title>
            <link>http://www.medworm.com/index.php?rid=5515292&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1329121.do</link>
            <description>New research indicates that initial hospital admission rates predict readmission rates for CHF in the US, and that these figures vary greatly by region. It's time to reduce incentives to use hospital services, say researchers. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515292</comments>
            <pubDate>Fri, 16 Dec 2011 21:15:00 +0100</pubDate>
            <guid isPermaLink="false">5515292</guid>        </item>
        <item>
            <title>FDA approves AtriCure AF ablation system</title>
            <link>http://www.medworm.com/index.php?rid=5515293&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1328937.do</link>
            <description>The FDA has approved the AtriCure Synergy Ablation System for the treatment of AF in patients undergoing open concomitant CABG surgery and/or valve replacement or repair. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515293</comments>
            <pubDate>Fri, 16 Dec 2011 20:15:00 +0100</pubDate>
            <guid isPermaLink="false">5515293</guid>        </item>
        <item>
            <title>Another Maryland doc charged with overstenting</title>
            <link>http://www.medworm.com/index.php?rid=5515294&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1328455.do</link>
            <description>A member of the Maryland Health Care Commission committee, tasked with helping to prevent a repeat of the Dr Mark Midei case, is accused of the same type of inappropriate practice. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515294</comments>
            <pubDate>Fri, 16 Dec 2011 16:45:00 +0100</pubDate>
            <guid isPermaLink="false">5515294</guid>        </item>
        <item>
            <title>Riata ICD lead &quot;alert&quot; is now a class I recall</title>
            <link>http://www.medworm.com/index.php?rid=5524468&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1328237.do</link>
            <description>The US FDA has designated a recent physician advisory letter relating to St Jude Medical's Riata family of ICD leads as a class I recall, the most serious. The letter, issued last month, warned doctors that more leads than it first thought were affected by a problem related to insulation failure. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524468</comments>
            <pubDate>Fri, 16 Dec 2011 14:30:00 +0100</pubDate>
            <guid isPermaLink="false">5524468</guid>        </item>
        <item>
            <title>Riata ICD lead 'alert' is now a class I recall</title>
            <link>http://www.medworm.com/index.php?rid=5515295&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1328237.do</link>
            <description>The US FDA has designated a recent physician advisory letter relating to St Jude Medical's Riata family of ICD leads as a class I recall, the most serious. The letter, issued last month, warned doctors that more leads than it first thought were affected by a problem related to insulation failure. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515295</comments>
            <pubDate>Fri, 16 Dec 2011 14:30:00 +0100</pubDate>
            <guid isPermaLink="false">5515295</guid>        </item>
        <item>
            <title>Chewing khat increases risk in cardiac patients</title>
            <link>http://www.medworm.com/index.php?rid=5494820&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325677.do</link>
            <description>Researchers in the Middle East are warning doctors about the practice of chewing khat leaves, previously described as a &quot;smokeless gun,&quot; which they have shown results in worse outcomes among ACS patients. Far from being benign, this plant contains constituents similar to amphetamines, but neither physicians nor users understand the risks, they say. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494820</comments>
            <pubDate>Mon, 12 Dec 2011 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5494820</guid>        </item>
        <item>
            <title>Bleeding risk scores provide mixed results, especially in intermediate-risk patients</title>
            <link>http://www.medworm.com/index.php?rid=5494821&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1326307.do</link>
            <description>Overall, the bleeding risk scores were able to identify patients at high risk for bleeding but had limited ability to identify patients at intermediate risk, report investigators. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494821</comments>
            <pubDate>Mon, 12 Dec 2011 20:00:13 +0100</pubDate>
            <guid isPermaLink="false">5494821</guid>        </item>
        <item>
            <title>&quot;Striking&quot; variation in PCI/CABG across Ontario hospitals</title>
            <link>http://www.medworm.com/index.php?rid=5494822&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1326089.do</link>
            <description>A large study in Ontario has identified a threefold variation in the ratio of PCI to CABG, depending on which hospital a patient attends. The widest range was seen among those with multivessel disease, and the results indicate that proper, unbiased discussion with each patient is needed to determine the best course of treatment for each individual, say the authors and accompanying editorialists. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494822</comments>
            <pubDate>Mon, 12 Dec 2011 17:00:00 +0100</pubDate>
            <guid isPermaLink="false">5494822</guid>        </item>
        <item>
            <title>Aspirin a safe, low-cost option for preventing recurrent VTE after anticoagulation stopped</title>
            <link>http://www.medworm.com/index.php?rid=5494823&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325937.do</link>
            <description>Investigators say the reduction in recurrent VTE risk, which was achieved without an increased risk of bleeding, makes aspirin an attractive treatment option for the extended prevention of recurrent VTE once oral anticoagulation is stopped. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5494823</comments>
            <pubDate>Mon, 12 Dec 2011 14:30:45 +0100</pubDate>
            <guid isPermaLink="false">5494823</guid>        </item>
        <item>
            <title>More concern voiced over Pfizer's Lipitor deals</title>
            <link>http://www.medworm.com/index.php?rid=5486685&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325607.do</link>
            <description>Pfizer's tactics to try to retain sales in the face of generic competition is again the subject of concern, this time in a Perspective in the New England Journal of Medicine. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486685</comments>
            <pubDate>Fri, 09 Dec 2011 16:00:53 +0100</pubDate>
            <guid isPermaLink="false">5486685</guid>        </item>
        <item>
            <title>There's a (cath-lab) app for that! iPad collects and streams real-time data to families, colleagues</title>
            <link>http://www.medworm.com/index.php?rid=5486686&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325499.do</link>
            <description>The iPad application collects clinical information during the coronary catheterization procedure and sends the information directly to the device, which allows clinicians to show patients the entire cardiovascular diagnostic workup and procedure. In some cases, the families can watch the entire cath procedure unfold in real time. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486686</comments>
            <pubDate>Fri, 09 Dec 2011 15:30:28 +0100</pubDate>
            <guid isPermaLink="false">5486686</guid>        </item>
        <item>
            <title>Waiting game: ACC, SCAI, HRS await details on CMS prepayment audits</title>
            <link>http://www.medworm.com/index.php?rid=5486687&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325457.do</link>
            <description>Cardiology organizations appear to be scrambling to get more information from the CMS as to just what kinds of procedures will be affected by the new prepayment audit programs in 11 states and are asking the CMS to hear their concerns and opinions about the proposal for Florida. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486687</comments>
            <pubDate>Fri, 09 Dec 2011 14:00:04 +0100</pubDate>
            <guid isPermaLink="false">5486687</guid>        </item>
        <item>
            <title>FDA advisors: Thumbs down on CardioMEMS implantable PA-pressure monitor for HF</title>
            <link>http://www.medworm.com/index.php?rid=5486688&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325423.do</link>
            <description>UPDATED // The device isn't ready for prime time, the advisory panel said to regulators; problems with its pivotal trial, it said, obscure whether benefit exceeds risk in heart-failure patients. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486688</comments>
            <pubDate>Thu, 08 Dec 2011 23:10:25 +0100</pubDate>
            <guid isPermaLink="false">5486688</guid>        </item>
        <item>
            <title>Stroke risk reduced with treatment of prehypertension</title>
            <link>http://www.medworm.com/index.php?rid=5486689&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325375.do</link>
            <description>A new meta-analysis shows that these patients who take any class of antihypertensive medication have a significantly lowered risk of stroke. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486689</comments>
            <pubDate>Thu, 08 Dec 2011 21:30:40 +0100</pubDate>
            <guid isPermaLink="false">5486689</guid>        </item>
        <item>
            <title>Gastric bypass has weight-independent metabolic benefits</title>
            <link>http://www.medworm.com/index.php?rid=5486690&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325345.do</link>
            <description>Gastric bypass appears to improve insulin levels, HbA1c, fasting glucose, LDL, apolipoprotein B, and triglyceride levels, although vitamin deficiency is a concern, especially in teenagers. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486690</comments>
            <pubDate>Thu, 08 Dec 2011 20:15:32 +0100</pubDate>
            <guid isPermaLink="false">5486690</guid>        </item>
        <item>
            <title>&quot;Everything you want to know about bleeding in AF patients&quot;: European consensus</title>
            <link>http://www.medworm.com/index.php?rid=5486691&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325317.do</link>
            <description>A new executive summary of a consensus document on bleeding risk assessment and management in atrial-fibrillation patients has been made available from the European Heart Rhythm Association. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486691</comments>
            <pubDate>Thu, 08 Dec 2011 19:15:38 +0100</pubDate>
            <guid isPermaLink="false">5486691</guid>        </item>
        <item>
            <title>COMPAS in print: Remote monitoring of pacemakers safely cuts clinic visits</title>
            <link>http://www.medworm.com/index.php?rid=5486692&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325263.do</link>
            <description>Problems aren't found at most scheduled pacemaker follow-ups, so remote monitoring allows for fewer, more productive visits and can lighten the healthcare system's load, researchers say. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486692</comments>
            <pubDate>Thu, 08 Dec 2011 16:30:12 +0100</pubDate>
            <guid isPermaLink="false">5486692</guid>        </item>
        <item>
            <title>Bill Boden returns to VA, takes post in Albany</title>
            <link>http://www.medworm.com/index.php?rid=5486693&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1323747.do</link>
            <description>The COURAGE and AIM-HIGH investigator is taking on new responsibilities in the upper Hudson Valley after about five years in the Buffalo area. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486693</comments>
            <pubDate>Thu, 08 Dec 2011 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">5486693</guid>        </item>
        <item>
            <title>FDA advisors mostly positive on expanding CRT-D indications to lower-risk patients</title>
            <link>http://www.medworm.com/index.php?rid=5486694&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1325013.do</link>
            <description>The advisory panel's main quibbles were with the subset data on which they had to rely to make their decisions and with the QRS duration cutoff proposed by the sponsor. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486694</comments>
            <pubDate>Thu, 08 Dec 2011 13:30:59 +0100</pubDate>
            <guid isPermaLink="false">5486694</guid>        </item>
        <item>
            <title>ADVISE iFR study published</title>
            <link>http://www.medworm.com/index.php?rid=5486695&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324957.do</link>
            <description>In contrast to fractional flow reserve, which assesses stenosis severity when coronary resistance is stable and minimized with the administration of adenosine, the new adenosine-independent index of stenosis severity is calculated when coronary resistance is minimized at rest. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486695</comments>
            <pubDate>Wed, 07 Dec 2011 21:00:00 +0100</pubDate>
            <guid isPermaLink="false">5486695</guid>        </item>
        <item>
            <title>FDA investigating serious bleeding events with dabigatran</title>
            <link>http://www.medworm.com/index.php?rid=5486696&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324923.do</link>
            <description>The agency wants to know whether bleeding events are occurring more commonly than would be expected based on data from the RE-LY trial. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486696</comments>
            <pubDate>Wed, 07 Dec 2011 19:45:31 +0100</pubDate>
            <guid isPermaLink="false">5486696</guid>        </item>
        <item>
            <title>Echo key to identifying early signs of cardiac damage in cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=5486697&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324821.do</link>
            <description>The cardiotoxic effects of cancer treatments range from relatively benign arrhythmias and hypertension to potentially lethal conditions such as thromboembolism, MI, and cardiomyopathy. Experts say echocardiography could play a bigger role in detecting adverse effects early on. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486697</comments>
            <pubDate>Wed, 07 Dec 2011 18:00:34 +0100</pubDate>
            <guid isPermaLink="false">5486697</guid>        </item>
        <item>
            <title>Is the right ventricle the Achilles' heel of the athlete's heart?</title>
            <link>http://www.medworm.com/index.php?rid=5486698&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324733.do</link>
            <description>In a group of 40 marathoners, triathletes, and alpine skiers competing in a long-distance event, researchers documented transient dysfunction of the right ventricle that returned to normal within one week of the race. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486698</comments>
            <pubDate>Wed, 07 Dec 2011 14:30:48 +0100</pubDate>
            <guid isPermaLink="false">5486698</guid>        </item>
        <item>
            <title>Childhood obesity interventions aimed at nutrition, activity pay off</title>
            <link>http://www.medworm.com/index.php?rid=5476393&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324565.do</link>
            <description>Researchers say it is difficult from their review to identify which interventions are better than others, but they say it's clear that strategies should focus on seeking to change environments, rather than just the behavior of individuals. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5476393</comments>
            <pubDate>Wed, 07 Dec 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5476393</guid>        </item>
        <item>
            <title>ADT for prostate cancer not linked to CV death</title>
            <link>http://www.medworm.com/index.php?rid=5476394&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324695.do</link>
            <description>A meta-analysis has found that, in contrast to other research, prostate-cancer patients who receive androgen-deprivation therapy are not at a higher risk for fatal cardiovascular events. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5476394</comments>
            <pubDate>Tue, 06 Dec 2011 22:30:56 +0100</pubDate>
            <guid isPermaLink="false">5476394</guid>        </item>
        <item>
            <title>FDA skeptical before CardioMEMS implant advisory panel</title>
            <link>http://www.medworm.com/index.php?rid=5476395&amp;cid=s_38373_7_f&amp;fid=38373&amp;url=http%3A%2F%2Fwww.theheart.org%2Farticle%2F1324649.do</link>
            <description>The agency will question the handling of some patients who received the pulmonary-artery pressure-sensor implant in the pivotal CHAMPION trial. (Source: theHeart.org)</description>
            <author>theHeart.org</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5476395</comments>
            <pubDate>Tue, 06 Dec 2011 21:30:44 +0100</pubDate>
            <guid isPermaLink="false">5476395</guid>        </item>
    </channel>
</rss>

